Correction of the HLA-G(*)01012 genomic sequence

Tissue Antigens

Volumn 49, Issue 6, 1997, Pages 673-674

  Yamashita, T ^a,b   Fujii, T ^a   Tokunaga, K ^b,c   Tadokoro, K ^b   Juji, T ^b   Taketani, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

BeWo choriocarcinoma cell line; HLA G; Polymerase chain reaction; Single strand conformation polymorphism

Indexed keywords

HLA ANTIGEN;

ARTICLE; GENE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0030969987     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02823.x     Document Type: Article

References (5)

1. Ellis SA, Palmer MS, McMichael AJ. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J Immunol 1990: 144: 731-735.
2. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1995. Tissue Antigens 1995: 46: 1-18.
3. Tamaki J, Arimura Y, Koda T et al. Heterogeneity of HLA-G genes identified by polymerase chain reaction/single strand conformational polymorphism (PCR/SSCP). Microbiol Immunol 1993: 37: 633-640.
4. Yamashita T, Fujii T, Watanabe Y et al. HLA-G gene polymorphism in a Japanese population. Immunogenetics 1996: 44: 186-191.
5. Geraghty DE, Koller BH, Orr HT. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci U S A 1987: 84: 9145-9149.